Law360, New York (August 13, 2012, 10:34 PM ET) -- A Tennessee federal judge ruled Wednesday that Pfizer Inc. and other brand-name and generic makers of digestion medication Reglan cannot be held liable for injuries allegedly caused by generic versions of the product, although brand-name makers still have to contend with claims associated with the brand-name versions.
U.S. District Judge S. Thomas Anderson granted summary judgment to brand-name companies on claims in seven lawsuits brought by plaintiffs who took metoclopramide, the generic name for Reglan, ruling they couldn't be held liable under state law for injuries...
Drugmakers Freed From Generic Reglan Claims In Tenn. Suits
To view the full article, take a free trial now.
